Carfilzomib
99%
- Product Code: 64895
CAS:
868540-17-4
| Molecular Weight: | 719.91 g./mol | Molecular Formula: | C₄₀H₅₇N₅O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | 204-208°C | Boiling Point: | |
| Density: | Storage Condition: | -20°C |
Product Description:
Carfilzomib is primarily used in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. It is specifically prescribed for patients who have not responded well to other treatments or have experienced a relapse. The drug works by inhibiting proteasomes, which are complexes that break down proteins in cells. By blocking this process, carfilzomib causes the accumulation of damaged proteins in cancer cells, leading to their death. It is often administered intravenously in combination with other medications, such as dexamethasone, to enhance its effectiveness. Due to its potent mechanism, it is crucial for healthcare providers to monitor patients for potential side effects, including cardiac issues, respiratory problems, and kidney dysfunction.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | WHITE TO OFF WHITE SOLID |
| PURITY | 98.5 |
| CARBON BY ELEMENTAL ANALYSIS | 65.0 % 68.0 % |
| NITROGEN BY ELEMENTAL ANALYSIS | 8.5 % 10.8 % |
| NMR | CONSISTENT |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.025 | 10-20 days | £87.98 |
+
-
|
| 0.100 | 10-20 days | £262.36 |
+
-
|
| 0.500 | 10-20 days | £805.17 |
+
-
|
| 1.000 | 10-20 days | £1,402.25 |
+
-
|
Carfilzomib
Carfilzomib is primarily used in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. It is specifically prescribed for patients who have not responded well to other treatments or have experienced a relapse. The drug works by inhibiting proteasomes, which are complexes that break down proteins in cells. By blocking this process, carfilzomib causes the accumulation of damaged proteins in cancer cells, leading to their death. It is often administered intravenously in combination with other medications, such as dexamethasone, to enhance its effectiveness. Due to its potent mechanism, it is crucial for healthcare providers to monitor patients for potential side effects, including cardiac issues, respiratory problems, and kidney dysfunction.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :